It has been demonstrated that NF-κB is activated in cancer cells by several types of chemotherapy and by radiation, and that in a number of instances this response inhibits the radiotherapy and chemotherapy-induced death of the cancer cells (13). This evidence concerns the gene NFKB1 and cancer.